Vanda Pharmaceuticals Q3 EPS $0.23 Beats $0.07 Estimate, Sales $59.485M Beat $58.32M Estimate

Vanda Pharmaceuticals (NASDAQ:VNDA) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.07 by 228.57 percent. This is a 15 percent increase over earnings of $0.2 per share from

Benzinga · 11/06/2019 21:41

Vanda Pharmaceuticals (NASDAQ:VNDA) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.07 by 228.57 percent. This is a 15 percent increase over earnings of $0.2 per share from the same period last year. The company reported quarterly sales of $59.485 million which beat the analyst consensus estimate of $58.32 million by 2.00 percent. This is a 21.06 percent increase over sales of $49.135 million the same period last year.